Boon-Falleur; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boon-Falleur; Thierry.The latest application filed is for "immunogenic polypeptides encoded by mage minigenes and uses thereof".

Company Profile

0.73.40

Boon-Falleur; Thierry - Brussels BE
Boon-Falleur; Thierry - Bruxelles BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for modulating activity of T lymphocytes Grant 8,951,747 - Demotte , et al. February 10, 2	2015-02-10
Tumour rejection antigens Grant 8,519,109 - Huang , et al. August 27, 2	2013-08-27
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof App 20130216563 - Berinstein; Neil ; et al.	2013-08-22
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 8,257,717 - Berinstein , et al. September 4, 2	2012-09-04
Tumor associated amino acids and uses therefor Grant 8,247,379 - Martelange , et al. August 21, 2	2012-08-21
Method For Modulating Activity Of T Lymphocytes App 20120196363 - DEMOTTE; Nathalie ; et al.	2012-08-02
MAGE-C2 antigenic peptides and uses thereof Grant 8,143,011 - Ma , et al. March 27, 2	2012-03-27
Mage-c2 Antigenic Peptides And Uses Thereof App 20110305722 - MA; Wenbin ; et al.	2011-12-15
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof App 20110250234 - Berinstein; Neil ; et al.	2011-10-13
Lage-1 tumor associated nucleic acids Grant 7,998,483 - Lethe , et al. August 16, 2	2011-08-16
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 7,851,212 - Berinstein , et al. December 14, 2	2010-12-14
MAGE-C2 antigenic peptides and uses thereof Grant 7,785,881 - Van Pel , et al. August 31, 2	2010-08-31
Method For Modularting Activity Of T Lymphocytes App 20100136597 - Demotte; Nathalie ; et al.	2010-06-03
Isolated proteins MAGE-4 and MAGE-41 App 20100009437 - Gaugler; Beatrice ; et al.	2010-01-14
Lage-1 Tumor Associated Nucleic Acids App 20090274716 - Lethe; Bernard ; et al.	2009-11-05
MAGE-C2 antigenic peptides and uses therefor App 20090233315 - Ma; Wenbin ; et al.	2009-09-17
Tumour Rejection Antigens App 20090209034 - Huang; Lan-Qing ; et al.	2009-08-20
Mage-a3 Peptides Presented By Hla-dr1 Molecules App 20090203124 - Zhang; Yi ; et al.	2009-08-13
Isolated GAGE-7B and 8 proteins Grant 7,572,885 - De Backer , et al. August 11, 2	2009-08-11
LAGE-1 tumor associated nucleic acids Grant 7,563,870 - Lethe , et al. July 21, 2	2009-07-21
MAGE-C2 antigenic peptides and uses thereof Grant 7,547,517 - Ma , et al. June 16, 2	2009-06-16
Isolated proteins MAGE-4 and MAGE-41 Grant 7,495,074 - Guagler , et al. February 24, 2	2009-02-24
MAGE-C2 antigenic peptides and uses thereof App 20080311652 - Pel; Aline Van ; et al.	2008-12-18
Tumor Associated Amino Acids And Uses Therefor App 20080299078 - Martelange; Valerie ; et al.	2008-12-04
Tumor associated nucleic acids and uses therefor Grant 7,411,042 - Martelange , et al. August 12, 2	2008-08-12
MAGE peptides presented by HLA class II molecules Grant 7,388,072 - Zhang , et al. June 17, 2	2008-06-17
MAGE-A3 peptides presented by HLA class II molecules Grant 7,371,845 - Zhang , et al. May 13, 2	2008-05-13
Tumor antigens and CTL clones isolated by a novel procedure Grant 7,351,409 - Chaux , et al. April 1, 2	2008-04-01
Mage C2 antigenic peptides and uses thereof Grant 7,348,007 - Pel , et al. March 25, 2	2008-03-25
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor Grant RE40,089 - Boon-Falleur , et al. February 19, 2	2008-02-19
MAGE-A4 antigenic peptides and uses thereof Grant 7,311,914 - Zhang , et al. December 25, 2	2007-12-25
Isolated GAGE-7B and 8 proteins App 20070219349 - Backer; Olivier De ; et al.	2007-09-20
MAGE-3 peptides presented by HLA class II molecules Grant 7,252,825 - Chaux , et al. August 7, 2	2007-08-07
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof Grant 7,199,231 - Guagler , et al. April 3, 2	2007-04-03
MAGE-A1 peptides presented by HLA class II molecules Grant 7,157,091 - Van Snick , et al. January 2, 2	2007-01-02
MAGE-A3 peptides presented by HLA class II molecules App 20060211091 - Zhang; Yi ; et al.	2006-09-21
Isolated proteins MAGE-4 and MAGE-41 App 20060127356 - Gaugler; Beatrice ; et al.	2006-06-15
MAGE-A3 peptides presented by HLA class II molecules Grant 7,049,413 - Zhang , et al. May 23, 2	2006-05-23
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 7,022,819 - Lucas , et al. April 4, 2	2006-04-04
Tumor associated nucleic acids and uses therefor Grant 7,001,999 - Martelange , et al. February 21, 2	2006-02-21
Tumor associated nucleic acids and uses therefor App 20060024742 - Martelange; Valerie ; et al.	2006-02-02
Mage C2 antigenic peptides and uses thereof App 20050255553 - Pel, Aline Van ; et al.	2005-11-17
Isolated peptides which bind to HLA-A24 molecules and uses thereof App 20050249743 - Boon-Falleur, Thierry ; et al.	2005-11-10
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-6 and uses thereof Grant 6,946,289 - Guagler , et al. September 20, 2	2005-09-20
Isolated nucleic acid molecules which encode GAGE genes and uses thereof Grant 6,939,707 - van der Bruggen , et al. September 6, 2	2005-09-06
Cancer-associated nucleic acids and polypeptides App 20050181370 - De Smet, Charles ; et al.	2005-08-18
Mage-A12 antigenic peptides and uses thereof Grant 6,897,288 - Heidecker , et al. May 24, 2	2005-05-24
LAGE-1 tumor associated nucleic acids App 20040234541 - Lethe, Bernard ; et al.	2004-11-25
MAGE-C2 antigenic peptides and uses thereof App 20040214779 - Ma, Wenbin ; et al.	2004-10-28
Tumor antigens and CTL clones isolated by a novel procedure App 20040185033 - Chaux, Pascal ; et al.	2004-09-23
Lage-1 tumor associated nucleic acids Grant 6,794,131 - Lethe , et al. September 21, 2	2004-09-21
Endogenous retrovirus tumor associated nucleic acids and antigens Grant 6,770,456 - Coulie , et al. August 3, 2	2004-08-03
MAGE peptides presented by HLA class II molecules App 20040077045 - Zhang, Yi ; et al.	2004-04-22
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,710,172 - Chaux , et al. March 23, 2	2004-03-23
MAGE-A4 antigenic peptides and uses thereof App 20040033541 - Zhang, Yi ; et al.	2004-02-19
Immunogenic polypetides encoded by mage minigenes and uses thereof App 20040033234 - Berinstein, Neil ; et al.	2004-02-19
Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules Grant 6,682,731 - Townsend , et al. January 27, 2	2004-01-27
Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof Grant 6,680,191 - Lucas , et al. January 20, 2	2004-01-20
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Hla-cw 1601/mage-1 Derived Peptides, And Methods For Treating Said Individuals Grant 6,680,056 - van der Bruggen , et al. January 20, 2	2004-01-20
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Human Leukocyte Antigen Tyrosinase Derived Peptides, And Methods For Treating Said Individuals Grant 6,669,946 - Boon-Falleur , et al. December 30, 2	2003-12-30
Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof Grant 6,667,037 - Ooms , et al. December 23, 2	2003-12-23
Isolated peptides which bind to HLA-Cw6 molecules and uses thereof App 20030228308 - Zhang, Yi ; et al.	2003-12-11
Isolated peptides which bind to HLA-B18 molecules and uses thereof App 20030228325 - Bilsborough, Janine ; et al.	2003-12-11
Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens Grant 6,638,512 - Boel , et al. October 28, 2	2003-10-28
MAGE-3 peptides presented by HLA class ll molecules App 20030170792 - Chaux, Pascal ; et al.	2003-09-11
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof App 20030170256 - Lucas, Sophie ; et al.	2003-09-11
Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof App 20030166837 - Bruggen, Pierre van der ; et al.	2003-09-04
Isolated GAGE-7B and 8 proteins App 20030157651 - Backer, Olivier De ; et al.	2003-08-21
Methods for diagnosing a disorder by assaying for MAGE-3 Grant 6,599,699 - Guagler , et al. July 29, 2	2003-07-29
Method for determining BAGE expression App 20030138854 - Boel, Pascale ; et al.	2003-07-24
Recombinant Adenoviral Vectors For Human Tumour Gene Therapy App 20030082150 - BOON-FALLEUR, THIERRY ; et al.	2003-05-01
MAGE-A3 peptides presented by HLA class II molecules App 20030049723 - Zhang, Yi ; et al.	2003-03-13
Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B families and uses thereof App 20020176865 - Lucas, Sophie ; et al.	2002-11-28
MAGE antigenic peptides which bind HLA-B35 and HLA-B44 App 20020164654 - Luiten, Rosalie ; et al.	2002-11-07
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 6,475,783 - Lucas , et al. November 5, 2	2002-11-05
Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals App 20020128200 - Boon-Falleur, Thierry ; et al.	2002-09-12
Isolated nucleic acid molecules which encode GAGE genes and uses thereof App 20020127613 - Bruggen, Pierre van der ; et al.	2002-09-12
Tumor associated nucleic acids and uses therefor App 20020115142 - Martelange, Valerie ; et al.	2002-08-22
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,407,063 - Luiten , et al. June 18, 2	2002-06-18
Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules Grant 6,379,901 - Boon-Falleur , et al. April 30, 2	2002-04-30
MAGE-3 peptides presented by HLA class II molecules Grant 6,369,211 - Chaux , et al. April 9, 2	2002-04-09
Isolated nucleic acid molecules which encode tumor rejection antigens found in dage Grant 6,339,149 - Coulie , et al. January 15, 2	2002-01-15
Mage-3 peptides presented by HLA class II molecules Grant 6,291,430 - Chaux , et al. September 18, 2	2001-09-18
Isolated nonapeptides presented by HLA molecules, and uses thereof Grant 6,222,012 - Boon-Falleur , et al. April 24, 2	2001-04-24
Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors Grant 6,201,111 - Brichard , et al. March 13, 2	2001-03-13
Leukemia associated genes Grant 6,130,052 - Van Baren , et al. October 10, 2	2000-10-10
Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof Grant 6,063,900 - Melief , et al. May 16, 2	2000-05-16
Method for screening for possible presence of cancer Grant 6,022,692 - Coulie , et al. February 8, 2	2000-02-08
Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof Grant 6,017,705 - Lurquin , et al. January 25, 2	2000-01-25
Precursor processed to at least one tumor rejection antigen presented by HLA-A2 Grant 6,001,975 - Brichard , et al. December 14, 1	1999-12-14
Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof Grant 5,997,872 - Lucas , et al. December 7, 1	1999-12-07
Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof Grant 5,939,526 - Gaugler , et al. August 17, 1	1999-08-17
Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 Grant 5,856,091 - Brichard , et al. January 5, 1	1999-01-05
Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 Grant 5,854,203 - Brichard , et al. December 29, 1	1998-12-29
Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides Grant 5,846,826 - Coulie , et al. December 8, 1	1998-12-08
Methods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursor Grant 5,837,476 - Brichard , et al. November 17, 1	1998-11-17
Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. Grant 5,830,753 - Coulie , et al. November 3, 1	1998-11-03
Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene Grant 5,759,783 - Lurquin , et al. June 2, 1	1998-06-02
Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules Grant 5,695,994 - Boon-Falleur , et al. December 9, 1	1997-12-09
Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof Grant 5,686,068 - Melief , et al. November 11, 1	1997-11-11
Isolated peptides derived from tumor rejection antigens, and their use Grant 5,648,226 - Van den Eynde , et al. July 15, 1	1997-07-15
Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 Grant 5,620,886 - Brichard , et al. April 15, 1	1997-04-15
Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor Grant 5,612,201 - De Plaen , et al. March 18, 1	1997-03-18
Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof Grant 5,591,430 - Townsend , et al. January 7, 1	1997-01-07
Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof Grant 5,589,334 - Coulie , et al. December 31, 1	1996-12-31
Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors Grant 5,571,711 - van der Bruggen , et al. November 5, 1	1996-11-05
Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof Grant 5,554,724 - Melief , et al. September 10, 1	1996-09-10
Isolated, tyrosinase derived peptides and uses thereof Grant 5,530,096 - Wolfel , et al. June 25, 1	1996-06-25
Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 Grant 5,512,444 - Patard , et al. April 30, 1	1996-04-30
Isolated nucleic acid molecules which encode MAGE derived nonapeptides Grant 5,462,871 - Boon-Falleur , et al. October 31, 1	1995-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.